Stachyra, K.; Dudzisz-Śledź, M.; Bylina, E.; Szumera-Ciećkiewicz, A.; Spałek, M.J.; Bartnik, E.; Rutkowski, P.; Czarnecka, A.M.
Merkel Cell Carcinoma from Molecular Pathology to Novel Therapies. Int. J. Mol. Sci. 2021, 22, 6305.
https://doi.org/10.3390/ijms22126305
AMA Style
Stachyra K, Dudzisz-Śledź M, Bylina E, Szumera-Ciećkiewicz A, Spałek MJ, Bartnik E, Rutkowski P, Czarnecka AM.
Merkel Cell Carcinoma from Molecular Pathology to Novel Therapies. International Journal of Molecular Sciences. 2021; 22(12):6305.
https://doi.org/10.3390/ijms22126305
Chicago/Turabian Style
Stachyra, Karolina, Monika Dudzisz-Śledź, Elżbieta Bylina, Anna Szumera-Ciećkiewicz, Mateusz J. Spałek, Ewa Bartnik, Piotr Rutkowski, and Anna M. Czarnecka.
2021. "Merkel Cell Carcinoma from Molecular Pathology to Novel Therapies" International Journal of Molecular Sciences 22, no. 12: 6305.
https://doi.org/10.3390/ijms22126305
APA Style
Stachyra, K., Dudzisz-Śledź, M., Bylina, E., Szumera-Ciećkiewicz, A., Spałek, M. J., Bartnik, E., Rutkowski, P., & Czarnecka, A. M.
(2021). Merkel Cell Carcinoma from Molecular Pathology to Novel Therapies. International Journal of Molecular Sciences, 22(12), 6305.
https://doi.org/10.3390/ijms22126305